Manufacturer
5 recalls in our database name University Compounding Pharmacy as the manufacturing or recalling firm.
Of the 5 recalls from University Compounding Pharmacy we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 1 (20%) are Severe.
The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.
Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.
University Compounding Pharmacy is voluntarily recalling Testosterone Cypionate Injection due to lack of assurance of sterility. The recall affects 178.2 mL of the product nationwide.
University Compounding Pharmacy is voluntarily recalling PGE-1, 20 mcg/mL Injection in Normal Saline due to lack of assurance of sterility.
University Compounding Pharmacy is voluntarily recalling Testosterone Cypionate/Testosterone Propionate Injection due to lack of assurance of sterility.
University Compounding Pharmacy is voluntarily recalling PGE-1 injections due to lack of assurance of sterility. The recall affects nationwide distribution.
University Compounding Pharmacy is voluntarily recalling Testosterone CYP (Sesame Oil) 200mg/mL Injection due to lack of assurance of sterility.